作者: Alessandro Morotti , Stefania Rocca , Giovanna Carrà , Giuseppe Saglio , Mara Brancaccio
DOI: 10.1016/J.BLRE.2016.11.004
关键词:
摘要: Myeloproliferative neoplasms (MPNs) are defined according to the 2008 World Health Organization (WHO) classification and recent 2016 revision. Over years, several genetic lesions have been associated with development of MPNs, important consequences for identifying unique biomarkers specific developing targeted therapies. Defining genotype-phenotype relationship in MPNs is essential identify driver somatic mutations that promote MPN maintenance order develop curative While studies human samples can putative mutations, murine models mandatory demonstrate causative role pre-clinical testing therapeutic interventions. This review focuses on mouse specifically developed assess pathogenetic roles gene found patients, as well MPN-like phenotypes identified genetically modified mice.